Relationship Between Natural Killer Cells’ Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2

Sponsors and Collaborators
Cancer and Leukemia Group B

Continue Reading

National Cancer Institute (NCI)

Contact identifier: NCT00896701
Principal Investigators
Sherif S. Farag, MD, PhD
Indiana University Melvin and Bren Simon Cancer Center Identifier